GenePlanet, a global leader in the field of preventive genetic testing is looking for an ambitious Business Development Manager to launch and grow a new oncology product on Serbian market.
With a presence in 45+ markets worldwide and a passionate team of over 250 employees, GenePlanet collaborates with more than 1,000 medical centers, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. Our tests empower individuals to take control of their own and their baby's health, and support doctors in their diagnostic and therapeutic decisions.
A High-Impact Rollout in Serbia
We are introducing an advanced cancer screening technology to the Serbian market — an innovative test capable of detecting signals for multiple cancer types from a single blood draw, backed by extensive scientific validation.
In this role, you will lead the strategic market launch of this advanced diagnostic portfolio in Serbia. Rather than just driving commercial growth, you will serve as a key bridge between our scientific innovation and the local medical ecosystem, establishing long-term, high-trust partnerships with healthcare leaders and institutions.
The role
We are seeking a self-driven, energetic, and results-oriented professional to open and develop the Serbian market: building local partnerships, establishing the sales infrastructure, and growing revenue with a special focus on this new cancer-screening breakthrough.
Your key responsibilities will include:
Would be an advantage
If you have a passion for healthcare and business development — and you want to be the one to bring a genuine cancer-screening breakthrough to the Serbian market — we encourage you to apply.

GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.
With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries.
The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures.
GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts.
With a presence in more than 35 countries worldwide and over 100,000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.